185 related articles for article (PubMed ID: 4428763)
1. [Results obtained with long-term benzbromarone therapy (author's transl)].
Bresnik W; Müller MM
Wien Klin Wochenschr; 1974 May; 86(10):283-7. PubMed ID: 4428763
[No Abstract] [Full Text] [Related]
2. [Effect of allopurinol (Zyloric) on uric acid, creatinine, fasting blood sugar and plasma lipids in patients with gout].
Günther R; Knapp E
Wien Klin Wochenschr; 1970 Jan; 82(5):78-82. PubMed ID: 5513199
[No Abstract] [Full Text] [Related]
3. [On the influence of Anturan on ric acid and plasma lipids in patients with gout].
Günther R; Herbst M; Knapp E; Siller K
Wien Klin Wochenschr; 1968 Jun; 80(24):473-8. PubMed ID: 5692866
[No Abstract] [Full Text] [Related]
4. [Gout and plasma lipid values].
Günther R; Knapp E; Siller K
Wien Klin Wochenschr; 1968 Jul; 80(29):577-81. PubMed ID: 5705694
[No Abstract] [Full Text] [Related]
5. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
Zöllner N; Griebsch A; Fink JK
Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261
[No Abstract] [Full Text] [Related]
6. [Long-term therapy with benzbromarone in uric arthritis].
Bröll H; Sochor H; Tausch G; Eberl R
Wien Med Wochenschr; 1975 Sep; 125(28):546-8. PubMed ID: 816095
[No Abstract] [Full Text] [Related]
7. [Gout and hyperlipemia].
Günther R; Herbst M; Knapp E
Wien Klin Wochenschr; 1967 Mar; 79(12):218-21. PubMed ID: 5585987
[No Abstract] [Full Text] [Related]
8. [Alterations of lipid metabolism in primary gout and hyperuircemia].
Mertz DP; Zaar I; Klöpfer-Zaar M; Henninges D; Thieme G; Scheier CA
Dtsch Med Wochenschr; 1971 Mar; 96(12):488-93. PubMed ID: 5548321
[No Abstract] [Full Text] [Related]
9. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
Mertz DP
MMW Munch Med Wochenschr; 1978 Oct; 120(42):1387-90. PubMed ID: 101792
[TBL] [Abstract][Full Text] [Related]
10. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
Mertz DP
Dtsch Med Wochenschr; 1976 Aug; 101(35):1288-92. PubMed ID: 782809
[No Abstract] [Full Text] [Related]
11. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
Mertz DP
Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
[No Abstract] [Full Text] [Related]
12. [Lipid disorders in gout and hyperuricemias].
Roux H; Vovan L; Dutertre P; Serratrice G; Recordier AM
Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):95-105. PubMed ID: 4705340
[No Abstract] [Full Text] [Related]
13. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
Matzkies F; Berg G
Dtsch Med Wochenschr; 1976 Oct; 101(43):1568-70. PubMed ID: 991731
[TBL] [Abstract][Full Text] [Related]
14. [Duplication of the left atrioventricular orifice (author's transl)].
Mertz DP; Rusteborg J
MMW Munch Med Wochenschr; 1975 Jan; 117(4):131-6. PubMed ID: 163431
[No Abstract] [Full Text] [Related]
15. [Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks].
Brzozowska-Jurkowska AM
Reumatologia; 1980; 18(3):287-92. PubMed ID: 6999575
[No Abstract] [Full Text] [Related]
16. [The interrelation between obesity, hyperinsulinism and hyperuricemia].
Uccella R
Minerva Med; 1975 Apr; 66(27):1287-94. PubMed ID: 1128797
[No Abstract] [Full Text] [Related]
17. [Contribution to the study of blood uric acid in normal individuals: correlation between blood cholesterol, triglycerides, total lipids, sugar and free fatty acids].
Godoy M; Giannini SD; Diament J; Forti N; Thomè O; Papaléo Neto M; Stellin JA; Coelho LT; Paula e Silva P
Rev Hosp Clin Fac Med Sao Paulo; 1971; 26(1):15-22. PubMed ID: 5553898
[No Abstract] [Full Text] [Related]
18. Abnormal regulation of carbohydrate metabolism in primary gout.
Diamond HS; Carter AC; Feldman EB
Ann Rheum Dis; 1974 Nov; 33(6):554-62. PubMed ID: 4441134
[No Abstract] [Full Text] [Related]
19. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
Matzkies F; Neuwirth R; Berg G
Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920
[TBL] [Abstract][Full Text] [Related]
20. [The effect of benzbromaron in gout patients with limited kidney function].
Kuzmits R; Bresnik W; Müller MM
Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
